<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Unipolar depression in adult primary care patients and general medical illness: Evidence for the efficacy of initial treatments
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Unipolar depression in adult primary care patients and general medical illness: Evidence for the efficacy of initial treatments
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Unipolar depression in adult primary care patients and general medical illness: Evidence for the efficacy of initial treatments
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bradley N Gaynes, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter P Roy-Byrne, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sara Swenson, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Solomon, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 15, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H225302">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depression is highly prevalent. Community surveys in 14 countries have estimated that the lifetime prevalence of unipolar depressive disorders is 12 percent [
         <a href="#rid1">
          1
         </a>
         ]. In patients with general medical illnesses such as diabetes or coronary heart disease, the prevalence of major depression is estimated at 10 to 20 percent [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         In addition, disability due to depression is common. The World Health Organization ranks unipolar major depression as the 11
         <sup>
          th
         </sup>
         greatest cause of disability and mortality in the world, among 291 diseases and causes of injury [
         <a href="#rid3">
          3
         </a>
         ]. In the United States, major depression ranks second among all diseases and injuries as a cause of disability, and dysthymia ranks 20
         <sup>
          th
         </sup>
         [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Major depression is also highly recurrent. Following recovery from one episode, the estimated rate of recurrence over two years is greater than 40 percent; after two episodes, the risk of recurrence within five years is approximately 75 percent [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         This topic reviews the efficacy of standard therapies for the initial treatment of depression in primary care patients and in patients with general medical illnesses. The choice of therapy for the initial treatment of depression and the general evidence of efficacy of standard therapies are discussed separately, as are the general principles and prognosis for the initial treatment of depression, and the evidence for therapies that are not typically used. Continuation and maintenance treatment of major depression, the treatment of resistant depression, and the clinical manifestations and diagnosis of depression are also discussed elsewhere.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90153.html" rel="external">
          "Unipolar depression in adults and initial treatment: General principles and prognosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90155.html" rel="external">
          "Unipolar depression in adults: Investigational and nonstandard treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14674.html" rel="external">
          "Unipolar depression in adults: Continuation and maintenance treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">
          "Unipolar depression in adults: Choosing treatment for resistant depression"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1721.html" rel="external">
          "Unipolar depression in adults: Assessment and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H225482">
         <span class="h1">
          DEPRESSED PRIMARY CARE PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many or most depressed outpatients are treated by primary care clinicians rather than psychiatrists [
         <a href="#rid6">
          6
         </a>
         ]. As an example, a representative survey of the United States household population found that among patients with unipolar major depression who received antidepressants (n = 363), primary care clinicians administered the treatment in 67 percent of the cases [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H84010274">
         <span class="h2">
          Evidence of efficacy
         </span>
        </p>
        <p class="headingAnchor" id="H225512">
         <span class="h3">
          Antidepressants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several types of antidepressants are available to treat unipolar major depression  (
         <a class="graphic graphic_table graphicRef53818" href="/z/d/graphic/53818.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef62488" href="/z/d/graphic/62488.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Selective serotonin reuptake inhibitors (SSRIs)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serotonin-norepinephrine reuptake inhibitors
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Atypical antidepressants
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serotonin modulators
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tricyclic antidepressants
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Monoamine oxidase inhibitors (MAOIs)
        </p>
        <p>
        </p>
        <p>
         The pharmacology, administration, and side effects of these drug classes are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14675.html" rel="external">
          "Selective serotonin reuptake inhibitors: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1713.html" rel="external">
          "Serotonin-norepinephrine reuptake inhibitors: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/85816.html" rel="external">
          "Atypical antidepressants: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/86265.html" rel="external">
          "Serotonin modulators: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1717.html" rel="external">
          "Tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1715.html" rel="external">
          "Monoamine oxidase inhibitors (MAOIs): Pharmacology, administration, safety, and side effects"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         SSRIs, serotonin-norepinephrine reuptake inhibitors, atypical antidepressants, and serotonin modulators are considered second-generation antidepressants, which are more commonly prescribed by primary care clinicians than tricyclics and MAOIs [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         For primary care patients with unipolar major depression, evidence supporting the use of antidepressants includes meta-analyses of randomized trials in patients who were not necessarily treated in primary care settings. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment", section on 'Efficacy of antidepressants'
         </a>
         .)
        </p>
        <p>
         In addition, antidepressants have demonstrated efficacy for major depression in primary care clinics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A pooled analysis of 28 randomized trials (5940 depressed, primary care patients who were typically treated for six to eight weeks) estimated that response rates (eg, reduction of baseline symptoms ≥50 percent) in patients who received second-generation antidepressants or placebo were 63 and 35 percent [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meta-analyses of 66 randomized trials (n &gt;15,000 depressed patients) found that the efficacy of SSRIs, other second-generation antidepressants, and tricyclics was superior to placebo [
         <a href="#rid9">
          9
         </a>
         ]. However, the clinical effects compared with placebo were small to moderate (eg, odds ratio for SSRIs 1.7, 95% CI 1.4-2.0; odds ratio for tricyclics 1.8, 95% CI 1.4-2.2).
        </p>
        <p>
        </p>
        <p>
         Several studies have evaluated whether some specific second-generation antidepressants are superior to others, and have found that the comparative efficacy is generally comparable. As an example, a review concluded that all second-generation antidepressants were typically suitable for the initial treatment of depression in primary care patients, based upon systematic reviews, conventional meta-analyses, and network meta-analyses of patients who were not necessarily treated by primary care clinicians [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         However, some studies suggest that specific antidepressants may differ in their efficacies. A network meta-analysis of 87 randomized trials (nearly 20,000 primary care patients with unipolar major depression) compared remission rates among 10 second-generation antidepressants (
         <a class="drug drug_general" data-topicid="8874" href="/z/d/drug information/8874.html" rel="external">
          citalopram
         </a>
         ,
         <a class="drug drug_general" data-topicid="8484" href="/z/d/drug information/8484.html" rel="external">
          duloxetine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9046" href="/z/d/drug information/9046.html" rel="external">
          escitalopram
         </a>
         ,
         <a class="drug drug_general" data-topicid="8465" href="/z/d/drug information/8465.html" rel="external">
          fluoxetine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8474" href="/z/d/drug information/8474.html" rel="external">
          fluvoxamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9656" href="/z/d/drug information/9656.html" rel="external">
          mirtazapine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9743" href="/z/d/drug information/9743.html" rel="external">
          paroxetine
         </a>
         , reboxetine,
         <a class="drug drug_general" data-topicid="9886" href="/z/d/drug information/9886.html" rel="external">
          sertraline
         </a>
         , and
         <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">
          venlafaxine
         </a>
         ), using indirect comparisons of the drugs (through their relative effect with a common comparator, usually placebo), as well as analyzing direct comparisons between drugs; the study concluded that the probability of remission was greatest with escitalopram [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         The comparative efficacy of antidepressants is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H84010955">
         <span class="h4">
          Adherence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antidepressant side effects can diminish adherence to treatment [
         <a href="#rid12">
          12
         </a>
         ]. In a randomized trial that compared
         <a class="drug drug_general" data-topicid="8465" href="/z/d/drug information/8465.html" rel="external">
          fluoxetine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9329" href="/z/d/drug information/9329.html" rel="external">
          desipramine
         </a>
         , and
         <a class="drug drug_general" data-topicid="8554" href="/z/d/drug information/8554.html" rel="external">
          imipramine
         </a>
         in 536 depressed primary care patients (doses were determined by the primary care physicians), discontinuation of treatment due to side effects during the first month was less with fluoxetine than desipramine and imipramine (9 versus 27 and 28 percent) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         Adherence to antidepressants, which is often poor in depressed primary care patients [
         <a href="#rid12">
          12
         </a>
         ], may be improved with education. However, it appears that both adherence and depressive symptoms improve more when education is combined with other interventions. A qualitative systematic review of 26 randomized trials (n &gt;11,000 patients with unipolar depression; nearly all treated within primary care) found that education alone was often not beneficial [
         <a href="#rid14">
          14
         </a>
         ]. By contrast, education that was part of collaborative care was frequently effective for adherence and depression outcomes. Education about adherence and collaborative care are each discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/90153.html" rel="external">
          "Unipolar depression in adults and initial treatment: General principles and prognosis", section on 'Adherence to treatment'
         </a>
         and
         <a class="local">
          'Collaborative care'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H84010413">
         <span class="h3">
          Collaborative care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Collaborative care integrates psychiatric treatment into primary care practices. Patients are treated by a team that usually includes a primary care clinician, a case manager who provides support and outreach to patients, and a mental health specialist (eg, psychiatrist) who provides consultation and case supervision [
         <a href="#rid15">
          15-21
         </a>
         ]. Other elements include a structured treatment plan that involves pharmacotherapy and/or other interventions (eg, patient education, cognitive-behavioral therapy, or problem solving therapy), scheduled follow-up visits, communication among the members of the treatment team, and measurement based care. (See
         <a class="medical medical_review" href="/z/d/html/14860.html" rel="external">
          "Using scales to monitor symptoms and treat depression (measurement based care)"
         </a>
         .)
        </p>
        <p>
         Many studies demonstrate that collaborative care improves depression outcomes [
         <a href="#rid22">
          22-26
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 37 randomized trials (n &gt;12,000 depressed patients) found a significant but clinically small effect favoring collaborative care over standard primary care, which persisted for up to five years; heterogeneity across studies was moderate [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent meta-analysis of 79 randomized trials (n &gt;24,000 depressed patients) that compared collaborative care with usual primary care (eg, pharmacotherapy alone) found that after six months, response (reduction of baseline symptoms ≥50 percent) occurred more often with collaborative care (relative risk 1.3, 95% CI 1.2-1.4); heterogeneity across studies was large [
         <a href="#rid19">
          19
         </a>
         ]. The benefits of collaborative care persisted for up to 24 months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A more recent meta-analysis of nine randomized trials (n &gt;2000 depressed patients) compared collaborative care with usual care during follow-up lasting 12 or more months, and found that remission occurred in more patients who received collaborative care [
         <a href="#rid28">
          28
         </a>
         ]. However, the clinical effect was small and heterogeneity across studies was large.
        </p>
        <p>
        </p>
        <p>
         In meta-analyses of randomized trials that compared collaborative care with usual care in primary care patients with depression and chronic conditions (eg, arthritis, asthma, cancer, coronary heart disease, diabetes, and HIV), improvement of depressive symptoms, psychosocial functioning, and mental and physical quality of life was greater with collaborative care than usual care [
         <a href="#rid29">
          29,30
         </a>
         ]. Analyses found that all-cause mortality was comparable for the two treatment groups, as was diabetic control in those studies addressing comorbid diabetes. However, one trial set goals concurrently for both diabetes and depression ("treat-to-target" or goal oriented therapy), and found statistically significant improvements in HbA1c as well as depression [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Other randomized trials have shown collaborative care is superior to usual care for treating depression in adolescents [
         <a href="#rid32">
          32
         </a>
         ], military personnel [
         <a href="#rid33">
          33
         </a>
         ], patients attending obstetrics and gynecology clinics [
         <a href="#rid34">
          34
         </a>
         ], socioeconomically disadvantaged pregnant and postpartum women [
         <a href="#rid35">
          35
         </a>
         ], and advanced cancer patients receiving palliative care [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         Integrating case managers and mental health clinicians into collaborative care programs through telemedicine may be effective for small practices that lack on-site mental health specialists [
         <a href="#rid21">
          21
         </a>
         ]. One 12-month randomized trial compared practice-based collaborative care (on-site primary care clinician and nurse care manager) with telemedicine-based collaborative care (on-site primary care clinician, as well as off-site nurse care manager and pharmacist by telephone and a psychologist and psychiatrist via videoconferencing) in 364 patients who screened positive for major depression [
         <a href="#rid37">
          37
         </a>
         ]. Assessments 18 months postbaseline found that remission occurred in more patients who received telemedicine-based collaborative care than practice-based collaborative care (26 versus 10 percent). However, poor implementation of practice-based collaborative care reduces confidence in these findings.
        </p>
        <p>
         In addition, case management administered by nurses through online messages to patients can improve depressive disorders, based upon a randomized trial (n = 208 patients) that compared online-based collaborative care with usual primary care [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Based upon the evidence, the American College of Physicians recommends that depressed primary care patients be treated within the context of collaborative care [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3972768357">
         <span class="h4">
          Factors associated with better outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Meta-analyses of randomized trials that compared collaborative care with usual care for primary care patients with depression indicate that the following factors predict better outcomes with collaborative care [
         <a href="#rid23">
          23,27
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Case management provided by nurses
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Case managers with a mental health background
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Regular, planned supervision of case managers and caseload review by a mental health specialist (typically a psychiatrist)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Good medication adherence
        </p>
        <p>
        </p>
        <p>
         In addition, a study of registry data found that patients with depression who are treated within a collaborative care model are more likely to improve if they follow up with a clinician within four weeks of initially presenting with depression [
         <a href="#rid40">
          40
         </a>
         ]. Among patients who do not improve after eight weeks of treatment, improvement is more likely to occur if they consult with a psychiatrist within the subsequent four weeks.
        </p>
        <p>
         One meta-analysis (37 randomized trials, n &gt;12,000 depressed patients) found that among patients who received collaborative care, the benefit of psychotherapy plus pharmacotherapy was comparable to the benefit of pharmacotherapy alone [
         <a href="#rid27">
          27
         </a>
         ]. In addition, depression outcomes did not improve by increasing the number of patient visits with the collaborative care case manager (which ranged from 2 to 14 among the trials). However, in a subsequent randomized trial that compared a single visit with a case manager with usual care in 375 primary care patients with depression, the intervention had no effect upon depression, suggesting that at least two visits may be necessary for an effective collaborative care program [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H249195765">
         <span class="h3">
          Psychotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although psychotherapy is generally administered in specialty psychiatric settings, randomized trials indicate that psychotherapy may also be effective in primary care settings [
         <a href="#rid42">
          42,43
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 15 trials (n &gt;1500 primary care patients with depressive disorders) compared psychotherapy (primarily cognitive-behavioral therapy or problem solving therapy) with a control condition (eg, usual care), and found a significant but clinically small effect favoring psychotherapy; heterogeneity across studies was moderate [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 30 randomized trials (n &gt;5100 patients) compared psychotherapy with a control condition (eg, usual care or placebo), and found a significant, clinically small to moderate effect favoring psychotherapies such as cognitive-behavioral therapy (CBT) and interpersonal psychotherapy [
         <a href="#rid45">
          45
         </a>
         ]. In addition, less resource intensive forms of CBT that involved minimal to no contact with patients appeared to provide effects comparable to face to face CBT.
        </p>
        <p>
        </p>
        <p>
         For primary care patients with mild to moderate episodes of unipolar major depression, limited evidence suggests that a relatively brief version of interpersonal psychotherapy (eg, administering 8 sessions rather than 16) may be suitable [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Although computerized versions of psychotherapy such as CBT have been developed, it is not clear that these are generally beneficial [
         <a href="#rid47">
          47
         </a>
         ]. As an example, a four-month, open-label trial randomly assigned primary care patients with depression (n = 691) to a commercial computerized CBT program plus usual care, a free computerized CBT program plus usual care, or usual care alone [
         <a href="#rid48">
          48,49
         </a>
         ]. Although patients assigned to computerized CBT received weekly telephone support, uptake and use of CBT was low, and improvement across the three groups was comparable.
        </p>
        <p class="headingAnchor" id="H265823822">
         <span class="h2">
          Efficacy of antidepressants compared with psychotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a practice guideline for internists and primary care clinicians who treat unipolar major depression [
         <a href="#rid50">
          50
         </a>
         ], the recommendations were based in part upon a pooled analysis of five randomized trials that compared second-generation antidepressants with CBT in 660 patients [
         <a href="#rid51">
          51
         </a>
         ]. Response with antidepressants or CBT was comparable (46 and 44 percent of patients). Additional information about the efficacy of antidepressants compared with psychotherapy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H225536">
         <span class="h1">
          DEPRESSION IN GENERAL MEDICAL ILLNESS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with general medical illnesses often suffer depressive syndromes, which are associated with increased physical symptoms; functional impairment; poor adherence to diet, exercise, and medications; and increased medical costs [
         <a href="#rid2">
          2,52,53
         </a>
         ]. As an example, depression predicts worse outcomes in stroke, myocardial infarction, and diabetes [
         <a href="#rid54">
          54-58
         </a>
         ]. Additionally, there is evidence that depression may increase the risk of developing general medical diseases [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4854.html" rel="external">
          "Psychosocial factors in acute coronary syndrome"
         </a>
         .)
        </p>
        <p>
         The diagnosis of depressive syndromes in the physically ill can be complicated; symptoms such as a dysphoria and lack of energy may be due to the physical illness and/or depression. Depression associated with specific general medical conditions is discussed separately.
        </p>
        <p>
         While treatment of depression in patients with general medical illnesses improves depression and functional outcomes (see
         <a class="local">
          'Antidepressants'
         </a>
         below), it is unclear whether treatment of depression alone improves general medical outcomes because of conflicting results across multiple studies [
         <a href="#rid16">
          16,56,59-65
         </a>
         ]. However, trials which use collaborative care approaches that are aimed at improving both comorbid depression outcomes and medical disease control have been successful. As an example, a 12-month, single-blind, randomized trial enrolled 214 patients with depression and poorly controlled diabetes, coronary heart disease, or both, and compared treatment as usual with collaborative care, in which a medically supervised nurse provided guideline-based care for managing depression and the general medical illness [
         <a href="#rid31">
          31
         </a>
         ]. Improvement of glycated hemoglobin levels, low-density lipoprotein (LDL) cholesterol, and systolic blood pressure levels, as well as depressive symptoms, was greater with collaborative care. By contrast, other studies have found that treating depression alone without including interventions for improving medical disease control after acute coronary syndromes does not improve mortality [
         <a href="#rid66">
          66,67
         </a>
         ]. Improvement in general medical outcomes may depend upon whether interventions are specifically targeted at both depression and improving medical disease control versus depression alone.
        </p>
        <p class="headingAnchor" id="H109766117">
         <span class="h2">
          Evidence of efficacy
         </span>
        </p>
        <p class="headingAnchor" id="H225548">
         <span class="h3">
          Antidepressants
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with unipolar major depression and comorbid general medical illnesses, evidence supporting the use of antidepressants includes meta-analyses of randomized trials in depressed patients who did not necessarily have comorbid illnesses. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment", section on 'Efficacy of antidepressants'
         </a>
         .)
        </p>
        <p>
         In addition, meta-analyses of randomized trials have demonstrated that antidepressants are effective for depression in patients with general medical conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 25 trials (1674 depressed patients with a variety of physical diseases) found that improvement of depressive symptoms occurred in more patients who received antidepressants than placebo (odds ratio 2.3, 95% CI 1.8-3.0). In addition, discontinuation of treatment for any reason was comparable for the two groups [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent meta-analysis of 25 trials (2338 patients with unipolar major depression and various comorbid general medical illnesses) found that response (reduction of baseline depression symptoms ≥50 percent ) occurred in more patients who received antidepressants than placebo (risk ratio 1.4, 95% CI 1.3-1.6); heterogeneity across studies was not significant [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of seven trials compared antidepressants with placebo in 306 patients with depression and diabetes mellitus, and found a significant, clinically moderate to large benefit favoring antidepressants; heterogeneity across studies was moderate [
         <a href="#rid65">
          65
         </a>
         ]. In addition, glycemic control was superior in patients who received antidepressants.
        </p>
        <p>
        </p>
        <p>
         Large trials have also found that antidepressants are effective for major depression in patients with coronary heart disease [
         <a href="#rid70">
          70
         </a>
         ]. In addition, antidepressants can be used to treat depression in patients with chronic pain. (See
         <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">
          "Pharmacologic management of chronic non-cancer pain in adults", section on 'Antidepressants'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H225554">
         <span class="h4">
          SSRIs
         </span>
         <span class="headingEndMark">
          —
         </span>
         For treatment of depression in patients with comorbid general medical disorders, selective serotonin reuptake inhibitors (SSRIs) have been more widely studied in high-quality trials than other antidepressant classes. As an example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A systematic review included a meta-analysis of 24 randomized trials that compared SSRIs with placebo for treating depression in 2133 patients with medical diseases such as asthma, cancer, coronary heart disease, diabetes, infection with the human immunodeficiency virus, Parkinson disease, and stroke [
         <a href="#rid53">
          53
         </a>
         ]. The analysis found a significant, small to moderate clinical effect favoring SSRIs over placebo; however, heterogeneity across studies was moderate and discontinuation of treatment due to adverse effects was greater with SSRIs. The review included a second meta-analysis of eight trials (411 patients) that compared SSRIs with tricyclics; both efficacy and tolerability were comparable for the two groups.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One randomized trial compared
         <a class="drug drug_general" data-topicid="9886" href="/z/d/drug information/9886.html" rel="external">
          sertraline
         </a>
         (50 to 200 mg/day) with cognitive-behavioral therapy (CBT; 10 sessions administered as group therapy) in patients with major depression plus type 1 or 2 diabetes mellitus [
         <a href="#rid71">
          71
         </a>
         ]. After three months, patients who responded (reduction of baseline depression symptoms ≥50 percent) continued treatment for another 12 months; depression outcomes at the end of 15 months were superior with sertraline than CBT, and the clinical effect was moderate.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H225560">
         <span class="h4">
          Other classes
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to their efficacy for the general treatment of unipolar major depression, serotonin-norepinephrine reuptake inhibitors appear to be efficacious for treating depression in patients with general medical comorbidity. One eight-week, randomized trial compared
         <a class="drug drug_general" data-topicid="8484" href="/z/d/drug information/8484.html" rel="external">
          duloxetine
         </a>
         (60 mg per day) with placebo in 311 patients ≥65 years of age with unipolar major depression; 75 percent had arthritis, diabetes mellitus, and/or vascular disease [
         <a href="#rid72">
          72
         </a>
         ]. Remission of depression occurred in more patients treated with duloxetine than placebo (27 versus 15 percent), and physical health status and pain relief were also superior with active treatment. In addition, discontinuation of treatment due to adverse effects was similar for duloxetine and placebo (approximately 9 percent of patients).
        </p>
        <p>
         Tricyclic antidepressants are also beneficial for depressed patients with medical comorbidity. A meta-analysis of eight randomized trials compared tricyclics with placebo for treating depression in 324 patients with general medical diseases, and found a significant, moderate to large clinical effect favoring tricyclics over placebo; heterogeneity across studies was small [
         <a href="#rid53">
          53
         </a>
         ]. However, there was a trend for a greater rate of dropout due to adverse effects in patients who received tricyclics.
        </p>
        <p class="headingAnchor" id="H159252102">
         <span class="h3">
          Collaborative care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Collaborative care integrates psychiatric treatment into primary care practices; general information about collaborative care is discussed elsewhere in this topic. (See
         <a class="local">
          'Collaborative care'
         </a>
         above.)
        </p>
        <p>
         For patients with depressive syndromes and comorbid general medical illnesses, collaborative care can improve depression and comorbid medical illnesses [
         <a href="#rid73">
          73
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Depression
         </strong>
         – Evidence that collaborative care can improve depression includes meta-analyses based upon 31 randomized trials in depressed patients (n &gt;10,000), which compared collaborative care with usual care; the primary findings included the following [
         <a href="#rid74">
          74
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Among patients with chronic physical conditions such as diabetes and/or cardiac disease, improvement of depression was greater with collaborative care than usual care, and the clinical effect was small to moderate. Also, the number and type of chronic conditions did not moderate the treatment effect.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The benefit of collaborative care for depression was comparable for patients with comorbid general medical illnesses and patients without comorbidity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General medical illnesses
         </strong>
         – Randomized trials indicate that collaborative care can also improve outcomes in general medical illnesses such as diabetes. As an example:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A meta-analysis of 7 trials lasting 12 to 52 weeks compared collaborative care with usual care in patients with comorbid depression and diabetes (n = 1895); improvement of depression was greater with collaborative care, as was improvement of diabetes [
         <a href="#rid75">
          75
         </a>
         ]. The benefits were small to moderate for both depression and glycemic outcomes, and improvement of diabetes appeared to be independent of improvement of depression. However, heterogeneity across studies was large.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A subsequent, open-label trial from India compared collaborative care with usual care in patients (n = 404) with at least moderate depressive symptoms plus type 2 diabetes mellitus and poor control of at least one of the following cardiometabolic indices: hemoglobin A
         <sub>
          1c
         </sub>
         , systolic blood pressure, or low-density lipoprotein cholesterol [
         <a href="#rid76">
          76
         </a>
         ]. Patients received study treatment for one year and were assessed two years after study entry. The primary outcome was reduction of baseline depressive symptoms ≥50 percent plus reduction of at least one of the following: hemoglobin A
         <sub>
          1c
         </sub>
         by at least 0.5 percentage points, systolic blood pressure by at least 5 mm Hg, or reduction of low-density lipoprotein cholesterol by at least 10 mg/dL. At the two-year assessment, improvement of depression plus at least one cardiometabolic parameter occurred in more patients who received collaborative care than usual care (72 versus 55 percent). However, the usual care in this study may differ from usual care in trials from health care systems in more developed countries.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H225566">
         <span class="h3">
          Psychotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Psychotherapy is effective for patients with general medical problems, based upon meta-analyses of randomized trials in depressed patients who did not necessarily have comorbid illnesses. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         .)
        </p>
        <p>
         In addition, psychotherapy has demonstrated efficacy for depressed patients with specific general medical diseases:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of four randomized trials (647 patients with depression and diabetes mellitus) compared psychotherapy (primarily cognitive-behavioral therapy) with usual care or a waiting list control; remission was more likely in patients treated with psychotherapy (odds ratio 3, 95% CI 2-5) [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent four-week randomized trial compared self-help cognitive-behavioral therapy (based upon a workbook, compact disc, and a brief weekly telephone call from a therapist) with a waiting list control in 82 patients with mild to moderate depression and rheumatic disease [
         <a href="#rid77">
          77
         </a>
         ]. Improvement of depressive symptoms was greater with active treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         More recently, a six-month randomized trial compared cognitive-behavioral therapy (weekly individual sessions lasting one hour) plus usual care (eg, antidepressants) with usual care alone in patients with unipolar major depression plus heart failure [
         <a href="#rid78">
          78
         </a>
         ]. Remission of depression was greater with cognitive-behavioral therapy plus usual care than usual care alone (51 versus 20 percent).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H432252235">
         <span class="h4">
          Digital interventions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although psychotherapy is traditionally delivered face-to-face with an individual patient, digital interventions delivered using mobile- or web-based platforms may increase access, and multiple randomized trials suggest this format may perhaps be efficacious [
         <a href="#rid79">
          79
         </a>
         ]. As an example, two randomized trials each lasting six weeks compared behavioral activation with usual care in primary care patients with clinically significant depressive symptoms (Patient Health Questionnaire-9 ≥10)  (
         <a class="graphic graphic_table graphicRef59307" href="/z/d/graphic/59307.html" rel="external">
          table 3
         </a>
         ), as well as hypertension and/or diabetes [
         <a href="#rid80">
          80
         </a>
         ]. Active treatment was administered by free smartphones with an application consisting of 18 sessions that could each be completed in less than 10 minutes; nurse assistants facilitated treatment through telephone calls. The primary findings were as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At the three-month follow-up, reduction of baseline symptoms ≥50 percent occurred in more patients who received digital behavioral activation than usual care:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Trial one (n = 790) – 41 versus 29 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Trial two (n = 410) – 53 versus 34 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Both trials also showed that quality of life and functioning were each superior with active treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         However, at the six-month follow-up, both trials found that outcomes were comparable for the two groups.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H225572">
         <span class="h3">
          Exercise
         </span>
         <span class="headingEndMark">
          —
         </span>
         For depressed patients with chronic medical illnesses, exercise can reduce depressive symptoms. However, it is not clear if exercise is beneficial for major depression or other depressive syndromes. In addition, our clinical experience is such that many depressed patients with general medical illnesses will not accept an exercise intervention due to fatigue, lack of motivation, or problems ambulating.
        </p>
        <p>
         Evidence supporting the use of exercise includes a meta-analysis of 90 randomized trials (n &gt;10,000 patients with depressive symptoms and chronic medical illnesses such as cancer, cardiovascular disease, chronic obstructive pulmonary disease, chronic pain and fibromyalgia, multiple sclerosis, and spinal cord injury) that compared exercise training with nonexercise control conditions [
         <a href="#rid81">
          81
         </a>
         ]. Studies of patients with a clinical diagnosis of depression were excluded. Exercise training consisted of an average of three sessions per week, 42 minutes per session, and lasted for an average of 17 weeks. Compared with control conditions, exercise led to a significant, clinically small to moderate reduction of depressive symptoms; heterogeneity across studies was moderate. In addition, larger antidepressant effects occurred in patients with greater baseline depressive symptoms and patients who achieved recommended levels of physical activity.
        </p>
        <p class="headingAnchor" id="H227832">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unipolar depression is highly prevalent, disabling, and recurrent. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence supporting the use of antidepressants for primary care patients with unipolar major depression includes randomized trials in patients who were not necessarily treated in primary care clinics. In addition, antidepressants have demonstrated efficacy for major depression in patients treated by primary care clinicians. (See
         <a class="local">
          'Antidepressants'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment", section on 'Efficacy of antidepressants'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adherence to antidepressants is often poor in depressed primary care patients, but can be improved with education combined with other interventions, such as collaborative care. (See
         <a class="local">
          'Adherence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Collaborative care integrates psychiatric treatment into primary care practices. Patients are treated by a team that usually includes a primary care clinician, a case manager, and a mental health specialist. Other elements include a structured treatment plan, scheduled follow-up visits, communication within the treatment team, and measurement based care. Many randomized trials demonstrate that collaborative care improves depression outcomes in primary care patients, and can improve outcomes for general medical illnesses. (See
         <a class="local">
          'Collaborative care'
         </a>
         above and
         <a class="local">
          'Collaborative care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Although psychotherapy is generally administered in specialty psychiatric settings, it is also effective in primary care settings. (See
         <a class="local">
          'Psychotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with general medical illnesses often suffer depressive syndromes, which are associated with increased physical symptoms; functional impairment; poor adherence to diet, exercise, and medications; and increased medical costs. (See
         <a class="local">
          'Depression in general medical illness'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence supporting the use of antidepressants for patients with unipolar major depression and comorbid general medical illnesses includes randomized trials in patients who did not necessarily have comorbid illnesses. In addition, antidepressants have demonstrated efficacy for major depression in patients with comorbidity. (See
         <a class="local">
          'Antidepressants'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment", section on 'Efficacy of antidepressants'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psychotherapy is effective for depression in patients with comorbid general medical problems, based upon randomized trials in depressed patients who did not necessarily have comorbid illnesses. In addition, psychotherapy has demonstrated efficacy for depressed patients with specific general medical diseases. (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         and
         <a class="local">
          'Psychotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exercise can reduce depressive symptoms in patients with chronic medical illnesses. However, it is not clear if exercise is beneficial for major depression or other depressive syndromes. (See
         <a class="local">
          'Exercise'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H628208702">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Wayne Katon, MD, now deceased, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kessler RC, Ormel J, Petukhova M, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry 2011; 68:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010; 67:1265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mojtabai R, Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry 2008; 69:1064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulrow CD, Williams JW Jr, Chiquette E, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000; 108:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linde K, Kriston L, Rücker G, et al. Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 2015; 13:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gartlehner G, Thaler K, Hill S, Hansen RA. How should primary care doctors select which antidepressants to administer? Curr Psychiatry Rep 2012; 14:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramsberg J, Asseburg C, Henriksson M. Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One 2012; 7:e42003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell AJ. Depressed patients and treatment adherence. Lancet 2006; 367:2041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996; 275:1897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong WW, Aslani P, Chen TF. Effectiveness of interventions to improve antidepressant medication adherence: a systematic review. Int J Clin Pract 2011; 65:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61:1042.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995; 273:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999; 56:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012; 10:CD006525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciechanowski P, Wagner E, Schmaling K, et al. Community-integrated home-based depression treatment in older adults: a randomized controlled trial. JAMA 2004; 291:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon GE, Ludman EJ. Should mental health interventions be locally grown or factory-farmed? Am J Psychiatry 2013; 170:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon W, Unützer J, Wells K, Jones L. Collaborative depression care: history, evolution and ways to enhance dissemination and sustainability. Gen Hosp Psychiatry 2010; 32:456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ekers D, Murphy R, Archer J, et al. Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord 2013; 149:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coventry P, Lovell K, Dickens C, et al. Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease. BMJ 2015; 350:h638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lagomasino IT, Dwight-Johnson M, Green JM, et al. Effectiveness of Collaborative Care for Depression in Public-Sector Primary Care Clinics Serving Latinos. Psychiatr Serv 2017; 68:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balasubramanian BA, Cohen DJ, Jetelina KK, et al. Outcomes of Integrated Behavioral Health with Primary Care. J Am Board Fam Med 2017; 30:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006; 166:2314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sighinolfi C, Nespeca C, Menchetti M, et al. Collaborative care for depression in European countries: a systematic review and meta-analysis. J Psychosom Res 2014; 77:247.
          </a>
         </li>
         <li class="breakAll">
          Agency for Healthcare Research and Quality. August 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm (Accessed on June 22, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson LC, Amick HR, Gaynes BN, et al. Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health 2013; 4:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363:2611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richardson LP, Ludman E, McCauley E, et al. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA 2014; 312:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engel CC, Jaycox LH, Freed MC, et al. Centrally Assisted Collaborative Telecare for Posttraumatic Stress Disorder and Depression Among Military Personnel Attending Primary Care: A Randomized Clinical Trial. JAMA Intern Med 2016; 176:948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melville JL, Reed SD, Russo J, et al. Improving care for depression in obstetrics and gynecology: a randomized controlled trial. Obstet Gynecol 2014; 123:1237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grote NK, Katon WJ, Russo JE, et al. COLLABORATIVE CARE FOR PERINATAL DEPRESSION IN SOCIOECONOMICALLY DISADVANTAGED WOMEN: A RANDOMIZED TRIAL. Depress Anxiety 2015; 32:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steel JL, Geller DA, Kim KH, et al. Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer 2016; 122:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortney JC, Pyne JM, Mouden SB, et al. Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry 2013; 170:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon GE, Ralston JD, Savarino J, et al. Randomized trial of depression follow-up care by online messaging. J Gen Intern Med 2011; 26:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crowley RA, Kirschner N, Health and Public Policy Committee of the American College of Physicians. The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: executive summary of an American College of Physicians position paper. Ann Intern Med 2015; 163:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bao Y, Druss BG, Jung HY, et al. Unpacking Collaborative Care for Depression: Examining Two Essential Tasks for Implementation. Psychiatr Serv 2016; 67:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dobscha SK, Corson K, Hickam DH, et al. Depression decision support in primary care: a cluster randomized trial. Ann Intern Med 2006; 145:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bortolotti B, Menchetti M, Bellini F, et al. Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry 2008; 30:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf NJ, Hopko DR. Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review. Clin Psychol Rev 2008; 28:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract 2009; 59:e51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linde K, Sigterman K, Kriston L, et al. Effectiveness of psychological treatments for depressive disorders in primary care: systematic review and meta-analysis. Ann Fam Med 2015; 13:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kontunen J, Timonen M, Muotka J, Liukkonen T. Is interpersonal counselling (IPC) sufficient treatment for depression in primary care patients? A pilot study comparing IPC and interpersonal psychotherapy (IPT). J Affect Disord 2016; 189:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           So M, Yamaguchi S, Hashimoto S, et al. Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity. BMC Psychiatry 2013; 13:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilbody S, Littlewood E, Hewitt C, et al. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. BMJ 2015; 351:h5627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Littlewood E, Duarte A, Hewitt C, et al. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Health Technol Assess 2015; 19:viii, xxi.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qaseem A, Barry MJ, Kansagara D, Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2016; 164:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gartlehner G, Gaynes BN, Amick HR, et al. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2016; 164:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 2005; 165:1260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor D, Meader N, Bird V, et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry 2011; 198:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramasubbu R, Patten SB. Effect of depression on stroke morbidity and mortality. Can J Psychiatry 2003; 48:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson JL, DeZee K, Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004; 140:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003; 26:2822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28:2668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams JW Jr, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004; 140:1015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23:934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 129:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003; 160:1823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev 2012; 12:CD008381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289:3106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010; :CD007503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iovieno N, Tedeschini E, Ameral VE, et al. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. Int Clin Psychopharmacol 2011; 26:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrak F, Herpertz S, Albus C, et al. Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial. Diabetes Care 2015; 38:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wise TN, Wiltse CG, Iosifescu DV, et al. The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract 2007; 61:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pence BW, Gaynes BN, Adams JL, et al. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS 2015; 29:1975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panagioti M, Bower P, Kontopantelis E, et al. Association Between Chronic Physical Conditions and the Effectiveness of Collaborative Care for Depression: An Individual Participant Data Meta-analysis. JAMA Psychiatry 2016; 73:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atlantis E, Fahey P, Foster J. Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ Open 2014; 4:e004706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali MK, Chwastiak L, Poongothai S, et al. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial. JAMA 2020; 324:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garnefski N, Kraaij V, Benoist M, et al. Effect of a cognitive behavioral self-help intervention on depression, anxiety, and coping self-efficacy in people with rheumatic disease. Arthritis Care Res (Hoboken) 2013; 65:1077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freedland KE, Carney RM, Rich MW, et al. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial. JAMA Intern Med 2015; 175:1773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torous J. Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder. JAMA 2021; 325:1839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Araya R, Menezes PR, Claro HG, et al. Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials. JAMA 2021; 325:1852.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herring MP, Puetz TW, O'Connor PJ, Dishman RK. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172:101.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 90154 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21199968" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Development of lifetime comorbidity in the World Health Organization world mental health surveys.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12893098" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical and health services relationships between major depression, depressive symptoms, and general medical illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23245608" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23842577" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10671391" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Multiple recurrences of major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21135326" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : National trends in the treatment for depression from 1998 to 2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18399725" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11059441" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Efficacy of newer medications for treating depression in primary care patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25583895" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22648236" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : How should primary care doctors select which antidepressants to administer?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22876296" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16798371" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Depressed patients and treatment adherence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8648870" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21849010" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Effectiveness of interventions to improve antidepressant medication adherence: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8857869" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A multifaceted intervention to improve treatment of depression in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15466678" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7897786" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Collaborative management to achieve treatment guidelines. Impact on depression in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10591288" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23076925" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Collaborative care for depression and anxiety problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15069044" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Community-integrated home-based depression treatment in older adults: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23545790" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Should mental health interventions be locally grown or factory-farmed?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20851265" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Collaborative depression care: history, evolution and ways to enhance dissemination and sustainability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23545062" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25687344" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27842470" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effectiveness of Collaborative Care for Depression in Public-Sector Primary Care Clinics Serving Latinos.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28379819" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Outcomes of Integrated Behavioral Health with Primary Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17130383" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25201482" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Collaborative care for depression in European countries: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25201482" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Collaborative care for depression in European countries: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23799670" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21190455" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Collaborative care for patients with depression and chronic illnesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25157724" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Collaborative care for adolescents with depression in primary care: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27294447" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Centrally Assisted Collaborative Telecare for Posttraumatic Stress Disorder and Depression Among Military Personnel Attending Primary Care: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24807320" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Improving care for depression in obstetrics and gynecology: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26345179" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : COLLABORATIVE CARE FOR PERINATAL DEPRESSION IN SOCIOECONOMICALLY DISADVANTAGED WOMEN: A RANDOMIZED TRIAL.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26970434" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23429924" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21384219" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Randomized trial of depression follow-up care by online messaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26121401" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: executive summary of an American College of Physicians position paper.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26567934" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Unpacking Collaborative Care for Depression: Examining Two Essential Tasks for Implementation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015865" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Depression decision support in primary care: a cluster randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18585531" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17555857" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19192368" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Psychological treatment of depression in primary care: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25583894" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effectiveness of psychological treatments for depressive disorders in primary care: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26432031" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Is interpersonal counselling (IPC) sufficient treatment for depression in primary care patients? A pilot study comparing IPC and interpersonal psychotherapy (IPT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23587347" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26559241" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26685904" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26857948" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26857743" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15956005" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Long-term risk for depressive symptoms after a medical diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21357876" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12776392" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Effect of depression on stroke morbidity and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8831391" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Depression and long-term mortality risk in patients with coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15197024" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Can treating depression improve disease outcomes?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14514586" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16249537" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The association of comorbid depression with mortality in patients with type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15197019" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The effectiveness of depression care management on diabetes-related outcomes in older patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10895843" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Depression and poor glycemic control: a meta-analytic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9178335" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9786808" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10834419" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14514497" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23235661" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12169073" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Sertraline treatment of major depression in patients with acute MI or unstable angina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12813116" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20238354" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Antidepressants for depression in physically ill people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20962663" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17244833" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25690005" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17590215" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26134881" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27602561" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Association Between Chronic Physical Conditions and the Effectiveness of Collaborative Care for Depression: An Individual Participant Data Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24727428" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32809002" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23281332" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Effect of a cognitive behavioral self-help intervention on depression, anxiety, and coping self-efficacy in people with rheumatic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26414759" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33974030" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33974019" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22271118" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
